Post-vaccination T cell immunity to omicron

In late 2021, the omicron variant of SARS Coronavirus 2 (SARS-CoV-2) emerged and replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against omicron has been challenging to estimate in clinical studies or is not available for all vaccines or populations of interest. T c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsen, Henning, Cobos Jiménez, Viviana, Sitaras, Ioannis, Bar-Zeev, Naor, Čičin-Šain, Luka, Higdon, Melissa M., Deloria-Knoll, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386871/
https://www.ncbi.nlm.nih.gov/pubmed/35990661
http://dx.doi.org/10.3389/fimmu.2022.944713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386871/
https://www.ncbi.nlm.nih.gov/pubmed/35990661
http://dx.doi.org/10.3389/fimmu.2022.944713

Ejemplares similares